TY  - JOUR

T1  - Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both

JO  - JAMA Oncology

UR  - http://eprints.whiterose.ac.uk/101667/

PY  - 2016/04/01

AU  - James ND

AU  - Pirrie SJ

AU  - Pope AM

AU  - Barton D

AU  - Andronis L

AU  - Goranitis I

AU  - Collins S

AU  - Daunton A

AU  - McLaren D

AU  - O’Sullivan J

AU  - Parker C et al

ED  - 

DO  - DOI: 10.1001/jamaoncol.2015.5570

VL  - 2

IS  - 4

SP  - 493

EP  - 493

Y2  - 2024/12/22

ER  -